Crohn's disease Archives -

Crowded psoriasis market cuts Lilly’s mirikizumab ambitions

https://pharmaphorum.com/news/crowded-psoriasis-market-cuts-lillys-mirikizumab-ambitions/

AbbVie/Allergan merger cleared in EU with brazikumab sell-off

https://pharmaphorum.com/news/abbvie-allergan-merger-cleared-in-eu-with-brazikumab-sell-off/

AZ buys back rights to Crohn’s candidate from Allergan, ahead of AbbVie merger

https://pharmaphorum.com/news/az-buys-back-rights-to-crohns-candidate-from-allergan-ahead-of-abbvie-merger/

Allergan says it will shed two drugs as AbbVie takeover looms

https://pharmaphorum.com/news/allergan-says-it-will-shed-two-drugs-as-abbvie-takeover-looms/

Abivax sets its course on colitis and Crohn’s

https://pharmaphorum.com/news/abivax-scolitis-crohns/

Takeda finalises buyout of TiGenix

https://pharmaphorum.com/news/japanese-takeda-finalises-tigenix-boyout/

Pioneering Crohn’s antibiotic treatment meets early target

https://pharmaphorum.com/news/pioneering-crohns-antibiotic-treatment-meets-early-target/

https://pharmaphorum.com/news/tigenixtakeda-stem-cell-therapy-backed-eu-regulators/

Janssen inks potential $1bn deal for IBD drug

https://pharmaphorum.com/news/janssen-inks-potential-1bn-deal-ibd-drug/

Search